It is disappointing that the share price is languishing, having almost halved since the recent high.
The other analyst covering AMI is Dylan Kelly from Ord Minnett (he asks most of the questions on the conference calls). He has a 95c target (03/05) despite Dargues grade issues and short-term operational concerns, due to Fed and Great Cobar growth prospects, plus balance sheet status and organic funding potential.
The quarterly will be of interest. More importantly, the Fed FS would need to be good (showing a true tier 1 asset) to attract M&A interest. Top tier execs normally wait for resource definition and de-risking before making a bid (to avoid reputational risk), even if they have to pay more.
- Forums
- ASX - By Stock
- Ann: Quarterly update and outlook - March 2022
It is disappointing that the share price is languishing, having...
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AMI (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $321.3M |
Open | High | Low | Value | Volume |
19.3¢ | 19.5¢ | 18.5¢ | $115.8K | 610.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 7999 | 21.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 3380 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
25 | 248105 | 0.190 |
11 | 482720 | 0.185 |
12 | 1570904 | 0.180 |
10 | 591125 | 0.175 |
9 | 524606 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.195 | 1717413 | 20 |
0.200 | 1234030 | 21 |
0.205 | 400868 | 6 |
0.210 | 1398970 | 11 |
0.215 | 1033600 | 6 |
Last trade - 15.59pm 03/07/2024 (20 minute delay) ? |
Featured News
AMI (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online